Login to My NLA Account

CLM-SAP 17: Guidelines in Clinical Lipidology: Concepts and Controversies

CLM-SAP 17 is an online self-assessment program that will objectively validate and enhance your knowledge of the available clinical practice guidelines and recommendations related to lipid management in order to reduce atherosclerotic cardiovascular risk. As guidelines and recommendations are routinely updated and released, and as different approaches are advocated, clinicians should become familiar with all available guidelines and recommendations in order to implement an informed, evidence-based approach to patient care. This program will review similarities and differences among these important guidelines in order to reduce gaps in implementation of evidence-based therapies.

Get real time feedback after each question, including a detailed critique and bibliographic references for further reading and receive a PDF copy of the program upon claiming CME/CE credit. Complete via computer or from tablet app for iPad and Android devices*.

Available Program Formats

Online Version: Get real-time feedback after each question. Detailed critique of each item along with bibliographic references.

You are not currently logged in. If you are an NLA Member, you can save time by logging in before visiting this activity.

Click here to take this activity as a Non-Member

Tablet Versions: Convenient tablet apps for iPad® and AndroidTM allow you to take the CLM-SAP with you, wherever there is an internet connection. Best of all, you can move seamlessly back and forth between our desktop web browser version and the tablet version.*

*NLA members only

Download from the App Store Download from the GooglePlay Store

CLM-SAP 17 Resources

The items below serve as resources for CLM-SAP 17:

References

The following citations serve as the principal references for this program. We encourage you to read these articles prior to beginning activity.

  1. Jacobson TA, Ito MK, Maki KC, et al. National Lipid Association recommendations for patient-centered management of dyslipidemia: part 1 - executive summary. J Clin Lipidol. 2014;8(5):473-88.
  2. Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(25 Pt B):2889-934.

Tables

The tables below can be found in the introductory section of the program. We recommend opening and downloading or saving these files for reference prior to beginning the activity.

Slides

We encourage you to review these slides prior to beginning activity.

Glossary of Terms

We recommend opening and downloading or saving these files for reference prior to beginning the activity.

 


Accreditation Information

You are not currently logged in. If you are an NLA Member, you can save time by logging in before visiting this activity.

Click here to take this activity as a Non-Member

Content Domain
This activity falls under the following content domain(s):

  • 7.2 Treatment Statements and Guidelines

Learning Objectives
This activity teaches to the following learning objective(s):

  1. Analyze the effectiveness of risk assessment approaches of the NLA’s Recommendations for Patient-Centered Management of Dyslipidemia and the 2013 ACC/AHA Guideline for the Treatment of Blood Cholesterol.
  2. Compare and contrast approaches to lipid management for ASCVD prevention advocated by the NLA’s Recommendations for Patient-Centered Management of Dyslipidemia with the 2013 ACC/AHA Guideline for the Treatment of Blood Cholesterol.
  3. Compare and contrast the role of lifestyle and pharmacologic therapies for ASCVD prevention advocated by the NLA’s Recommendations for Patient-Centered Management of Dyslipidemia with the 2013 ACC/AHA Guideline for the Treatment of Blood Cholesterol.
  4. Recognize differences in lipid management recommendations for special populations.